User login
Article Type
Changed
Thu, 07/05/2018 - 08:08
Click here to access Optimal Treatments for Cardiovascular Diseases
Table of Contents
- Roundtable Discussion : Anticoagulation Management
- The Pharmacist’s Role in Medication Optimization for Patients With Chronic Heart Failure
- Pharmacist Interventions to Reduce Modifiable Bleeding Risk Factors Using HAS-BLED in Patients Taking Warfarin
Publications
Topics
Sections
Click here to access Optimal Treatments for Cardiovascular Diseases
Table of Contents
- Roundtable Discussion : Anticoagulation Management
- The Pharmacist’s Role in Medication Optimization for Patients With Chronic Heart Failure
- Pharmacist Interventions to Reduce Modifiable Bleeding Risk Factors Using HAS-BLED in Patients Taking Warfarin
Click here to access Optimal Treatments for Cardiovascular Diseases
Table of Contents
- Roundtable Discussion : Anticoagulation Management
- The Pharmacist’s Role in Medication Optimization for Patients With Chronic Heart Failure
- Pharmacist Interventions to Reduce Modifiable Bleeding Risk Factors Using HAS-BLED in Patients Taking Warfarin
Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Consolidated Pubs: Do Not Show Source Publication Logo
Use ProPublica